SCHEMBL4924653

SCHEMBL4924653

CCOC(=O)c1ncccc1C1=C(c2cccc(Cl)c2OC)CCCC1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 1/20 0.42
TDP2 O95551 3/20 0.39
CSF1R P07333 1/20 0.38
MAPT P10636 2/20 0.37
NPSR1 Q6W5P4 2/20 0.37
LMNA P02545 1/20 0.37
GRM6 O15303 1/20 0.36
CDC7 O00311 1/20 0.36
DBF4 Q9UBU7 1/20 0.36
CTSA P10619 1/20 0.36
GABRA1 P14867 1/20 0.36
GABRA5 P31644 1/20 0.36
CYP1A2 P05177 1/20 0.36
POLB P06746 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
KMT2A Q03164 1/20 0.36
TDP1 Q9NUW8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4926630 0.82 CSF1R (0.43) BRD4CSF1RMAPTNPSR1LMNA
SCHEMBL4924658 0.81 CSF1R (0.42) BRD4CSF1RMAPTNPSR1LMNA
SCHEMBL4922991 0.79 GABRG2 (0.43) BRD4TDP2MAPTNPSR1LMNA
SCHEMBL1495328 0.75 BRD4 (0.60) BRD4TDP2MAPTNPSR1LMNA
SCHEMBL4924644 0.71 BRD4 (0.37) BRD4TDP2CSF1RCDC7GABRA1
SCHEMBL25780703 0.71 BRD4 (0.58) BRD4TDP2GABRA1GABRA5CYP1A2
SCHEMBL25780927 0.69 BRD4 (0.56) BRD4TDP2MAPTNPSR1LMNA
SCHEMBL16060393 0.68 ACHE (0.41) BRD4TDP2MAPTNPSR1CDC7
SCHEMBL27492257 0.68 BRD4 (0.58) BRD4TDP2MAPTCTSACYP1A2
SCHEMBL27968857 0.68 TSHR (0.58) MAPTLMNACYP1A2POLBCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080234335-A1 Cyclohexene Compounds GLAXO GROUP LIMITED (GB) 2008-09-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080234335-A1 Cyclohexene Compounds C1R, CYP1B1, CYP2C9 BRD4 1260/4885TDP2 3900/4885CSF1R 2002/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.